Intratumoral heterogeneity of Ki67 expression in early breast cancers exceeds variability between individual tumours
出版年份 2016 全文链接
标题
Intratumoral heterogeneity of Ki67 expression in early breast cancers exceeds variability between individual tumours
作者
关键词
-
出版物
HISTOPATHOLOGY
Volume 69, Issue 5, Pages 849-861
出版商
Wiley
发表日期
2016-06-06
DOI
10.1111/his.13007
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Tumor Heterogeneity in Breast Cancer
- (2015) Sunil Badve et al. ADVANCES IN ANATOMIC PATHOLOGY
- Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
- (2015) A. S. Coates et al. ANNALS OF ONCOLOGY
- Strategies for developing Ki67 as a useful biomarker in breast cancer
- (2015) Carsten Denkert et al. BREAST
- The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancer
- (2015) Matthias Christgen et al. HUMAN PATHOLOGY
- Ki67 Heterogeneity in Estrogen Receptor–Positive Breast Cancers
- (2015) Takanori Himuro et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Clinical management of breast cancer heterogeneity
- (2015) Dimitrios Zardavas et al. Nature Reviews Clinical Oncology
- Intra-tumor genetic heterogeneity and alternative driver genetic alterations in breast cancers with heterogeneous HER2 gene amplification
- (2015) Charlotte KY Ng et al. GENOME BIOLOGY
- Current breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases
- (2014) Lik Hang Lee et al. Scientific Reports
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- From genome to bedside: Are we lost in translation?
- (2013) Daniel F. Hayes BREAST
- A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases
- (2013) Gaetano Aurilio et al. EUROPEAN JOURNAL OF CANCER
- Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
- (2012) Hyesil Seol et al. MODERN PATHOLOGY
- How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists
- (2012) Zsuzsanna Varga et al. PLoS One
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies
- (2011) Quinci Romero et al. BMC CANCER
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started